Literature DB >> 9572672

Relationship between 2,5-hexanedione concentrations in nerve, serum, and urine alone or under co-treatment with different doses of methyl ethyl ketone, acetone, and toluene.

W Zhao1, J Misumi, T Yasui, K Aoki, T Kimura.   

Abstract

To ascertain the relationship among 2,5-hexanedione (2,5-HD) concentrations in nerve, serum and urine, rats were injected subcutaneously with 2.6 mmol/kg 2,5-HD alone, or together with 2.6 or 13.0 mmol/kg of methyl ethyl ketone, acetone and toluene. 2,5-HD concentrations in sciatic nerve (NC), serum (SC) and urine (UC) were determined, and the linear regression between each two of NC, SC, and UC were calculated. There was good correlation between NC and SC, SC and UC in the 2,5-HD alone group, and good correlation between NC and SC in the co-treated groups. Co-treatment solvent had little effect on the relationship between SC and NC. 13.0 mmol/kg co-treated solvent tended to decrease the regression coefficients compared with 2.6 mmol/kg co-treated solvent. These results show that SC can be used in estimating NC in the 2,5-HD alone or co-treated groups, and UC can be used in estimating SC in the 2,5-HD alone group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572672     DOI: 10.1023/a:1022402810695

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Behaviour of urinary 2,5-hexanedione in occupational co-exposure to n-hexane and acetone.

Authors:  A Cardona; D Marhuenda; M J Prieto; J Martí; J F Periago; J M Sánchez
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  Changes in autonomic function as determined by ECG R-R interval variability in sandal, shoe and leather workers exposed to n-hexane, xylene and toluene.

Authors:  K Murata; S Araki; K Yokoyama; K Yamashita; F Okajima; K Nakaaki
Journal:  Neurotoxicology       Date:  1994       Impact factor: 4.294

Review 3.  The enlarging view of hexacarbon neurotoxicity.

Authors:  P S Spencer; H H Schaumburg; M I Sabri; B Veronesi
Journal:  Crit Rev Toxicol       Date:  1980-10       Impact factor: 5.635

4.  Metabolic interaction between n-hexane and toluene in vivo and in vitro.

Authors:  L Perbellini; R Leone; M E Fracasso; F Brugnone; M S Venturini
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

5.  An experimental study on the combined effects of n-hexane and toluene on the peripheral nerve of the rat.

Authors:  Y Takeuchi; Y Ono; N Hisanaga
Journal:  Br J Ind Med       Date:  1981-02

Review 6.  Molecular mechanisms of diketone neurotoxicity.

Authors:  A P DeCaprio
Journal:  Chem Biol Interact       Date:  1985 Aug-Sep       Impact factor: 5.192

7.  Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione.

Authors:  A Cardona; D Marhuenda; J Martí; F Brugnone; J Roel; L Perbellini
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

8.  Urinalysis vs. blood analysis, as a tool for biological monitoring of solvent exposure.

Authors:  T Kawai; T Yasugi; K Mizunuma; S Horiguchi; M Ikeda
Journal:  Toxicol Lett       Date:  1992-12       Impact factor: 4.372

9.  An experimental study of the combined effects of n-hexane and methyl ethyl ketone.

Authors:  Y Takeuchi; Y Ono; N Hisanaga; M Iwata; M Aoyama; J Kitoh; Y Sugiura
Journal:  Br J Ind Med       Date:  1983-05

10.  Early diagnosis of n-hexane-caused neuropathy.

Authors:  C Pastore; D Marhuenda; J Marti; A Cardona
Journal:  Muscle Nerve       Date:  1994-09       Impact factor: 3.217

View more
  1 in total

1.  The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-hexanedione toxicity.

Authors:  Anna Ghelli; Anna Maria Porcelli; Claudia Zanna; Sara Vidoni; Stefano Mattioli; Anna Barbieri; Luisa Iommarini; Maria Pala; Alessandro Achilli; Antonio Torroni; Michela Rugolo; Valerio Carelli
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.